Peptide reference standards: what changes when the analyte is a chain

A defined sequence is not a defined substance

Small-molecule impurity work assumes a single structure with a small set of related substances that differ in a functional group. A peptide breaks that assumption in two directions at once. Up the chain, the related substances are other chains: one residue missing, one residue extra, one residue in the wrong configuration. Down at the level of the material, the substance is a salt of whatever counter-ion came out of purification, holding a variable amount of water, and the mass you weigh is not the mass of peptide.

Both facts land on the certificate. A peptide standard without a sequence, an observed mass and a counter-ion statement is not a standard for a peptide; it is a bottle with a name on it.

The impurity families worth knowing by name

• Deletion and truncation sequences. n-1 and n-2 chains from incomplete coupling or from chain termination. They are the most common peptide impurities and the hardest to resolve, because a single residue difference changes retention only slightly on a C18 gradient.
• Epimers. One residue inverted, usually at cysteine, histidine or serine, where the alpha proton is acidic enough to be removed during coupling or deprotection. The result is a diastereomer with almost identical chromatographic behaviour on an achiral column.
• Pyroglutamate formation. Cyclisation of an N-terminal glutamine or glutamic acid to pyroglutamate, losing ammonia or water. Common, spontaneous in acidic solution, and easily mistaken for the parent on a mass detector if the mass shift is not calculated.
• Deamidation. Asparagine and glutamine to aspartate and glutamate, through a succinimide intermediate that also produces the isoaspartyl form. Age and pH driven, so it accumulates on storage rather than in synthesis.
• Oxidation. Methionine to sulfoxide, tryptophan to several products, histidine to oxo-histidine. Fast in air, and the sulfoxide diastereomers separate.
• Disulfide scrambling. For cystine-containing peptides, the wrong pairing of half-cystines gives isoforms with the same mass and different activity.
• Counter-ion and water. Trifluoroacetate from purification, acetate after exchange, plus water that depends on how the lyophile was dried and how it has been stored.

What purity means for a peptide, and why the number moves

A chromatographic purity by UV at 214 nm measures the peptide backbone, which every related sequence shares. That makes it a good measure of how much of the UV-absorbing material is the main peak, and a poor measure of whether that main peak is the right sequence. Two peptides with the same area percent can differ by one residue.

Content is worse. For a small molecule the content is the purity after correcting for water and residual solvents. For a peptide the same calculation has to include the counter-ion, which can be ten percent by mass, and the result is reported in three different ways that are not interchangeable: gross weight, peptide content, and net peptide content. A method transferred between laboratories without saying which of the three was used will disagree by exactly the counter-ion and water correction.

Mass balance is therefore less useful than it is for small molecules, and orthogonal characterisation matters more: amino acid analysis for composition, mass spectrometry for the observed mass, and tandem mass spectrometry or sequencing for the sequence itself. qNMR is limited here by the molecular weight and by the number of exchangeable protons.

What the certificate has to carry

• The sequence, written out, with disulfide pairing and any non-natural residue defined.
• Theoretical and observed mass, with the ion species and charge state used.
• Identity evidence beyond mass: MS/MS fragmentation, amino acid analysis, or sequencing, because mass alone cannot distinguish a deletion from an insertion.
• Chromatographic purity with method, column, gradient and wavelength.
• Counter-ion identity and content, and whether the value is the free peptide or the salt.
• Water content by Karl Fischer, and residual trifluoroacetic acid where relevant.
• The content basis, stated explicitly as gross, peptide or net peptide.
• Storage and retest, including whether the material is hygroscopic and whether it should be equilibrated before weighing.

Why the impurity standards are usually custom items

For a small molecule, the related substances are eventually catalogue items, because the same impurity recurs across manufacturers and the synthesis is short. For a peptide the related substances are sequence-specific: the n-1 chain of one peptide has no use anywhere else, and the synthesis of a specific deletion sequence costs about as much as the parent. That has two consequences a buyer should expect.

First, a catalogue listing for a peptide impurity is a listing for a sequence that somebody already made, and availability is finite. Second, the sensible route for a new project is to have the sequences made against a defined specification rather than to search a catalogue for them: the questions above become a purchase specification, and the certificate is written to it.

The same logic explains why peptide work is often quoted rather than listed with a price. It is not commercial coyness; the sequence, the length and the purification difficulty set the cost, and none of them is known until the structure is in hand.

Labelled peptides as internal standards

Bioanalysis of a peptide almost always uses an isotopically labelled analogue of the same sequence, added before extraction so that losses cancel. Three properties decide whether it works: the label must sit on a residue that survives fragmentation, so the labelled and unlabelled forms co-elute and produce a distinguishable transition; the label incorporation must be high enough that the unlabelled fraction does not raise the lower limit of quantitation; and the labelled sequence must itself be pure, because a labelled n-1 chain gives a second, silent internal standard.

For this reason a labelled peptide certificate needs the label position and the isotopic enrichment stated, in addition to everything a normal peptide certificate carries. An enrichment figure quoted only as "99 percent" without saying whether it is isotopic or chemical is not enough to plan a method around.

Where peptide standards are actually used

Three uses dominate and they need different things. For assay of a peptide drug substance, the content basis matters most, because a systematic counter-ion error propagates into every result. For impurity identification, the individual deletion and epimer standards matter, and they are usually custom items rather than catalogue products. For bioanalysis, an isotopically labelled analogue of the same sequence is the internal standard, and its own purity and label incorporation decide the quantitation.

The characteristic failure is a standard whose sequence is right and whose content basis is unstated. The peak appears where it should, the assay runs, and the result is wrong by the mass of the trifluoroacetate.

What to ask

• What is the sequence, and is it confirmed by fragmentation or by sequencing rather than by mass alone?
• What is the counter-ion, at what content, and is the stated content gross, peptide or net peptide?
• Which related sequences were detected and at what level, with the method?
• How was the material dried, and should it be equilibrated before weighing?
• Is an isotopically labelled form of the same sequence available for bioanalysis?

Peptide items sit in the same parent-drug grouping as small-molecule impurities, so the impurity standards index shows what is listed for a given active substance, and the labelled standards guide covers the internal standard side in more detail.